Definium Therapeutics Inc (FRA:MMQ0)
€ 38.6 +1.9 (+5.18%) Market Cap: 5.15 Bil Enterprise Value: 4.86 Bil PE Ratio: 0 PB Ratio: 16.49 GF Score: 34/100

Definium Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 12:00PM GMT
Release Date Price: €16.95 (-3.97%)
Unidentified Company Representative

Conference, Definium Therapeutics, represented by their CFO, Brandi Roberts. Brandi, thanks so much for being here.

Brandi Roberts
Definium Therapeutics Inc - Chief Financial Officer

Thanks so much for having us. Couldn't be more excited.

Questions & Answers

Unidentified Company Representative

Well, certainly exciting times at Definium these days with a lot of key data points coming up. And I was hoping we could maybe start with the next key data point that we're going to see, which is the major depressive disorder data for 120.

Brandi Roberts
Definium Therapeutics Inc - Chief Financial Officer

Yeah.

Unidentified Company Representative

I'm so used to MM.

So, we're coming up on the phase three eMERGE data any week now. And one of the questions we get most frequently is understanding the translatability from GAD and depressive symptoms in GAD, which in phase two, 120 did a really good job of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot